Universal Fe/Mn Nanoadjuvant with T1/T2 MRI Self-Navigation and Gas Generation for Ideal Vaccines with Precise Tracking
Source abstract
Abstract
Because of the distinguished properties between nanovaccine and traditional vaccine, the precise guidelines for nanovaccines with an optimal vaccination strategy to induce ideal immunities are greatly desired for combating major diseases, including cancer and infections. Herein, we designed and synthesized a self-navigating nanoadjuvant composed of Fe-doped manganese carbonate and its nanovaccine via a facile method. First, the degradation of the nanoadjuvant under acidic milieu of immune cells in lymph nodes would generate T1 and T2 MR imaging (MRI) signals to reflect the transformation dynamics of the nanovaccine and inform us when the next vaccination needed. Under this guideline, nanovaccines with a precise vaccination strategy triggered robust antigen-specific immune responses and immunological memory to effectively prevent ovalbumin (OVA)-expressing melanoma relapse by activating dendritic cells via a stimulator of interferon genes (STING) signaling pathway and inducing antigen cross-presentation by shaping lysosome integrity with CO 2 generation and upregulating transporter associated antigen processing 1 (TAP-1) transporter. This study provides a universal nanoadjuvant with imaging self-guidance, immunopotentiating, and cross-priming activities for developing precise vaccines with an optimal immunization strategy to combat major diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology, The First Affiliated Hospital and Department of Chemistry, Jinan University, Guangzhou 510632, China
Funding
Government of Guangdong Province · Basic and Applied Basic Research Foundation of Guangdong Province · National Natural Science Foundation of China · University Innovation team project of Guangdong Province · Major Program for Tackling Key Problems of Industrial Technology in Guangzhou
References (63)
Show source-provided references
1. 10.1038/s41577-018-0119-y10.1038/s41577-018-0119-y ↗
2. 10.1038/nature1067310.1038/nature10673 ↗
3. 10.1038/s41422-020-0337-210.1038/s41422-020-0337-2 ↗
4. 10.1038/s41568-021-00346-010.1038/s41568-021-00346-0 ↗
5. 10.1016/j.ymthe.2020.09.03810.1016/j.ymthe.2020.09.038 ↗
6. 10.1021/acsnano.5b0201410.1021/acsnano.5b02014 ↗
7. 10.1002/adma.20130058310.1002/adma.201300583 ↗
8. 10.1021/acsnano.7b0904110.1021/acsnano.7b09041 ↗
9. 10.1002/adma.20210484910.1002/adma.202104849 ↗
10. 10.1016/j.mattod.2017.11.02210.1016/j.mattod.2017.11.022 ↗
11. 10.1038/s41565-020-0739-910.1038/s41565-020-0739-9 ↗
12. 10.1021/acsnano.8b0055810.1021/acsnano.8b00558 ↗
13. 10.1021/acsnano.2c0125210.1021/acsnano.2c01252 ↗
14. 10.1016/j.jconrel.2020.07.00810.1016/j.jconrel.2020.07.008 ↗
15. 10.1021/jacs.2c0326610.1021/jacs.2c03266 ↗
16. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
17. 10.1038/s41467-019-11157-110.1038/s41467-019-11157-1 ↗
18. 10.1016/j.tibtech.2022.03.01110.1016/j.tibtech.2022.03.011 ↗
19. 10.1038/s41565-020-00781-410.1038/s41565-020-00781-4 ↗
20. 10.1038/s41551-019-0503-310.1038/s41551-019-0503-3 ↗
21. 10.1038/s41467-021-23244-310.1038/s41467-021-23244-3 ↗
22. 10.1039/C8CS00028J10.1039/C8CS00028J ↗
23. 10.1002/adfm.20201063710.1002/adfm.202010637 ↗
24. 10.1038/s41392-023-01371-110.1038/s41392-023-01371-1 ↗
25. 10.1021/acsnano.2c0635010.1021/acsnano.2c06350 ↗
26. 10.1038/nmat482210.1038/nmat4822 ↗
27. 10.1038/s41551-022-00886-210.1038/s41551-022-00886-2 ↗
28. 10.1038/s41563-020-0793-610.1038/s41563-020-0793-6 ↗
29. 10.31635/ccschem.021.20200067010.31635/ccschem.021.202000670 ↗
30. 10.1021/acsnano.9b1010310.1021/acsnano.9b10103 ↗
31. 10.1021/acsnano.9b0597410.1021/acsnano.9b05974 ↗
32. 10.1038/s41392-020-0198-710.1038/s41392-020-0198-7 ↗
33. 10.1038/s41577-021-00524-z10.1038/s41577-021-00524-z ↗
34. 10.1038/s41422-020-00395-410.1038/s41422-020-00395-4 ↗
35. 10.1016/j.immuni.2018.03.01710.1016/j.immuni.2018.03.017 ↗
36. 10.1002/adfm.20170408910.1002/adfm.201704089 ↗
37. 10.1002/anie.20211722910.1002/anie.202117229 ↗
38. 10.1021/acsami.1c0892610.1021/acsami.1c08926 ↗
39. 10.1002/adma.20150022910.1002/adma.201500229 ↗
40. 10.1002/adfm.20190009510.1002/adfm.201900095 ↗
41. 10.1021/acsnano.9b0174010.1021/acsnano.9b01740 ↗
42. 10.1038/s41577-020-00479-710.1038/s41577-020-00479-7 ↗
43. 10.1038/s41590-021-01126-610.1038/s41590-021-01126-6 ↗
44. 10.1038/s41577-022-00707-210.1038/s41577-022-00707-2 ↗
45. 10.1016/j.jconrel.2021.01.03610.1016/j.jconrel.2021.01.036 ↗
46. 10.1038/s41467-022-33301-010.1038/s41467-022-33301-0 ↗
47. 10.1016/j.celrep.2020.10805310.1016/j.celrep.2020.108053 ↗
48. 10.1016/j.immuni.2018.03.00910.1016/j.immuni.2018.03.009 ↗
49. 10.1038/s41565-022-01098-010.1038/s41565-022-01098-0 ↗
50. 10.1038/s41587-019-0390-x10.1038/s41587-019-0390-x ↗
51. 10.1038/s41551-020-00624-610.1038/s41551-020-00624-6 ↗
52. 10.1038/s41577-019-0244-210.1038/s41577-019-0244-2 ↗
53. 10.1038/nri70510.1038/nri705 ↗
54. 10.1038/nri77810.1038/nri778 ↗
55. 10.1016/j.biomaterials.2022.12137110.1016/j.biomaterials.2022.121371 ↗
56. 10.1016/j.nantod.2020.10097510.1016/j.nantod.2020.100975 ↗
57. 10.1038/ni.319610.1038/ni.3196 ↗
58. 10.1038/onc.2008.31010.1038/onc.2008.310 ↗
59. 10.1021/acsnano.1c0823710.1021/acsnano.1c08237 ↗
60. 10.1038/nprot.2007.29610.1038/nprot.2007.296 ↗
61. 10.1016/j.cell.2020.08.02210.1016/j.cell.2020.08.022 ↗
62. 10.1038/ncomms1319310.1038/ncomms13193 ↗
63. 10.1016/j.matt.2020.08.02710.1016/j.matt.2020.08.027 ↗